
Long-term ibrutinib-rituximab vs FCR in CLL, procoagulant platelet sentinels in prevention of inflammatory bleeding, and new SERPINC1 variants in thrombophilia
Blood Podcast
00:00
Thrombophilia and Antithrombin
Jattergy believes that potential novel drug targets may emerge from the identification of subtle difference between phosphortital syrian exposing a poptotic versus pro coagulant platlets. In the final segment of to day's podcast, we will review a report published in blood entitled, two serpent one variants affecting englic oscillation of asperogene two 24 caused severe thrombo philia not detected by functional assays.
Transcript
Play full episode